SEC Info - NuGene International, Inc. - ‘8-K/A’ for 11/14/16

SEC Info℠

Home

Help

Please Sign In

NuGene International, Inc. – ‘8-K/A’ for 11/14/16 – ‘EX-16.1’

On: Friday, 4/14/17, at 11:28am ET · For: 11/14/16 · Accession #: 1615774-17-1675 · File #: 1-37940

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/14/17  NuGene International, Inc.        8-K/A:4,9  11/14/16    2:72K                                    S2 Filings LLC/FA

Amendment to Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K/A       Amendment to Current Report                         HTML     12K 
 2: EX-16.1     Letter re: Change in Certifying Accountant          HTML      5K

EX-16.1 — Letter re: Change in Certifying Accountant

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 16.1

Date: April 9, 2017

Office of the Chief Accountant

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Ladies and Gentlemen:

We have read the statements made by NuGene International, Inc., which we understand will be filed with the Commission, pursuant to Item 4.01 of Form 8-K, as part of the Company's Form 8-K report dated November 18, 2016. We agree with the statements concerning our Firm in such Form 8-K.

/s/ *Dov Weinstein & Co. C.P.A (lsr)*

Jerusalem, Israel

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K/A’ Filing	Date	Other Filings

Filed on:	4/14/17
	4/9/17
	11/18/16
For Period End:	11/14/16	8-K, NT 10-Q
		List all Filings

↑Top

Filing Submission 0001615774-17-001675 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)